Literature DB >> 29410314

Serum biomarker profiles suggest that atopic dermatitis is a systemic disease.

Judith L Thijs1, Ian Strickland2, Carla A F M Bruijnzeel-Koomen3, Stefan Nierkens4, Barbara Giovannone1, Edward F Knol1, Eszter Csomor2, Bret R Sellman5, Tomas Mustelin5, Matthew A Sleeman2, Marjolein S de Bruin-Weller3, Athula Herath2, Julia Drylewicz4, Richard D May2, DirkJan Hijnen6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29410314     DOI： 10.1016/j.jaci.2017.12.991

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  13 in total

Review 1.  Immunological Pathomechanisms of Spongiotic Dermatitis in Skin Lesions of Atopic Dermatitis.

Authors:  Ryoji Tanei; Yasuko Hasegawa
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

2.  The Atopic Dermatitis Control Tool: A High-Performance Tool for Optimal Support.

Authors:  Delphine Staumont-Sallé; Charles Taieb; Stephanie Merhand; Jason Shourick
Journal:  Acta Derm Venereol       Date:  2021-12-13       Impact factor: 3.875

3.  Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood.

Authors:  Tali Czarnowicki; Helen He; Talia Canter; Joseph Han; Rachel Lefferdink; Taylor Erickson; Stephanie Rangel; Naoya Kameyama; Hyun Je Kim; Ana B Pavel; Yeriel Estrada; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2019-10-15       Impact factor: 10.793

Review 4.  Keratinocytes: innate immune cells in atopic dermatitis.

Authors:  P Chieosilapatham; C Kiatsurayanon; Y Umehara; J V Trujillo-Paez; G Peng; H Yue; L T H Nguyen; F Niyonsaba
Journal:  Clin Exp Immunol       Date:  2021-02-15       Impact factor: 5.732

Review 5.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

Review 6.  Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.

Authors:  Thomas Litman
Journal:  APMIS       Date:  2019-05       Impact factor: 3.205

7.  Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis.

Authors:  Eric Simpson; Laurent Eckert; Abhijit Gadkari; Usha G Mallya; Min Yang; Lauren Nelson; Michelle Brown; Matt Reaney; Puneet Mahajan; Isabelle Guillemin; Mark Boguniewicz; David Pariser
Journal:  BMC Dermatol       Date:  2019-11-06

Review 8.  Disease Mechanisms in Atopic Dermatitis: A Review of Aetiological Factors.

Authors:  Jacob P Thyssen; Maria Rasmussen Rinnov; Christian Vestergaard
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

9.  The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.

Authors:  M de Bruin-Weller; A Gadkari; S Auziere; E L Simpson; L Puig; S Barbarot; G Girolomoni; K Papp; A E Pink; G Saba; T Werfel; L Eckert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-14       Impact factor: 6.166

10.  3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models.

Authors:  Li-Jung Kang; Eunjeong Oh; Chanmi Cho; HoKeun Kwon; Choong-Gu Lee; Jimin Jeon; Hyemi Lee; Sangil Choi; Seong Jae Han; Jiho Nam; Chi-Une Song; Hyunho Jung; Hye Young Kim; Eun-Jung Park; Eun-Ju Choi; Jooyoung Kim; Seong-Il Eyun; Siyoung Yang
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.